Roles of transient receptor potential canonical (TRPC) channels and reverse-mode Na+/Ca2+ exchanger on cell proliferation in human cardiac fibroblasts: Effects of transforming growth factor β1

Cell Calcium

Volumn 54, Issue 3, 2013, Pages 213-225

  Ikeda, Kenichi ^a   Nakajima, Toshiaki ^a   Yamamoto, Yumiko ^a   Takano, Nami ^a   Tanaka, Tomofumi ^a   Kikuchi, Hironobu ^a   Oguri, Gaku ^a   Morita, Toshihiro ^a   Nakamura, Fumitaka ^b   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Human cardiac fibroblast; NCX1; Proliferation; TGF 1, Angiotensin II; Transient receptor potential canonical (TRPC) channels; TRPC6

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; ANGIOTENSIN II; CALCIUM ION; GLYCEROL 2 ACETATE 1 OLEATE; HYPERFORIN; MEGLUMINE; MESSENGER RNA; SMALL INTERFERING RNA; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

HUMAN CARDIAC FIBROBLAST; NCX1; PROLIFERATION; REVERSE-MODE NA(+)/CA(2+) EXCHANGER; TGF-Β1, ANGIOTENSIN II; TRANSIENT RECEPTOR POTENTIAL CANONICAL (TRPC) CHANNELS; TRPC6;

ANGIOTENSIN II; CALCIUM; CALCIUM SIGNALING; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; DIGLYCERIDES; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; PHLOROGLUCINOL; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SODIUM-CALCIUM EXCHANGER; TERPENES; THAPSIGARGIN; THIOUREA; TRANSFORMING GROWTH FACTOR BETA1; TRPC CATION CHANNELS;

EID: 84883219467     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.06.005     Document Type: Article

References (60)

1. Weber K.T. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J. Hypertens. 2004, 22:47-50.
2. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
3. Camelliti P., Borg T.K., Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005, 65:40-51.
4. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodelling. Pharmacol. Ther. 2009, 123:255-278.
5. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF-β) signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 2011, 51:600-606.
6. Ramos-Mondragon R., Galindo C.A., Avila G. Role of TGF-β on cardiac structural and electrical remodeling. Vasc. Health Risk Manage. 2008, 4:1289-1300.
7. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ. Res. 1993, 73:413-423.
8. Campbell S.E., Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 1997, 29:1947-1958.
9. Gray M.O., Long C.S., Kalinyak J.E., Li H.T., Karliner J.S. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts. Cardiovasc. Res. 1998, 40:352-363.
10. Clapham D.E. Calcium signaling. Cell 1995, 80:259-268.
11. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signaling: dynamics, homeostasis and remodeling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
12. Kumaran C., Shivakumar K. Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1855-H1862.
13. 2+ in the cell-cycle in human fibroblasts-transitions between G1 and G0 and progression into S phase. Mol. Biol. Cell 1993, 4:293-302.
14. Pedersen S.F., Owsianik G., B.Nilius B. TRP channels: an overview. Cell Calcium 2005, 38:233-252.
15. Minke B., Cook B. TRP channel proteins and signal transduction. Physiol. Rev. 2002, 82:429-472.
16. Vazquez G., Wedel B.L., Aziz O., Trebak M., Putney J.W. The mammalian TRPC cation channels. Biochim. Biophys. Acta 2004, 1742:21-36.
17. Toko H., Shiojima I., Komuro I. Promotion of cardiac hypertrophy by TRPC-mediated calcium entry. J. Mol. Cell Cardiol. 2007, 42:481-483.
18. Wu X., Eder P., Chang B., Molkentin J.D. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. PNAS 2010, 107:7000-7005.
19. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., Olson E.N. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Invest. 2006, 116:3114-3126.
20. Bush E.W., Hood D.B., Papst P.J., Chapo J.A., Minobe W., Bristow M.R., Olson E.N., McKinsey T.A. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J. Biol. Chem. 2006, 281:33487-33496.
21. Nakayama H., Wilkin B.J., Bodi I., Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 2006, 20:1660-1670.
22. Onohara N., Nishida M., Inoue R., Kobayashi H., Sumimoto H., Sato Y., Mori Y., Nagao T., Kurose H. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 2006, 25:5305-5316.
23. Davis J., Burr A.R., Davis G.F., Birnbaumer L., Molkentin J.D. A TRPC6-dependent pathway for myoblast transdifferentiation and wound healing in vivo. Dev. Cell 2012, 23:705-715.
24. Harada M., Luo X., Qi X.Y., Tadevosyan A., Maguy A., Ordog B., Ledoux J., Kato T., Naud P., Voigt N., Shi Y., Kamiya K., Murohara T., Kodama I., Tardif J.C., Schotten U., Van Wagoner D.R., Dobrev D., Nattel S. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 2012, 126:2051-2064.
25. Xie J., Cha S.K., An S.W., Kuro O.M., Birnbaumer L., Huang C.L. Cardioprotection by klotho through downregulation of TRPC6 channels in the mouse heart. Nat. Commun. 2012, 3:1238.
26. Chen K., Mehta J.L., Li D., Joseph L., Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ. Res. 2004, 95:1167-1173.
27. 2+ waves and enhances gene expression in human pulmonary fibroblasts. Am. J. Respir. Cell Mol. Biol. 2012, 46:757-764.
28. Zhu Z., Tepel M., Neusser M., Zidek W. Transforming growth-factor β1 modulates angiotensin-II-induced calcium influx in vascular smooth-muscle. Eur. J. Clin. Invest. 1995, 25:317-321.
29. 2+ influx involves the type III IP3 receptor and regulates actin cytoskeleton. Am. J. Physiol. Renal Physiol. 2002, 282:F910-F920.
30. Kim J.H., Jain D., Tliba O., Yang B., Jester W.F., Panettieri R.A., Amrani Y., Pure E. TGF-β potentiates airway smooth muscle responsiveness to bradykinin. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L511-L520.
31. Roth-Eichhorn S., Eberheim A., Bode H.P., Gressner A.M. Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver. J. Hepatol. 1999, 30:612-620.
32. Yu L., Lin Q., Liao H., Feng J., Dong X., Ye J. TGF-β1 induces podocyte injury through Smad3-ERK-NF-(B pathway and Fyn-dependent TRPC6 phosphorylation. Cell. Physiol. Biochem. 2010, 26:869-878.
33. 2+ signals confer fibrogenesis in human atrial fibrillation. Circ. Res. 2010, 106:992-1003.
34. 2+ in cultured human pulmonary artery smooth muscle cells. Am. J. Physiol. Cell Physiol. 2005, 288:C245-C252.
35. 2+ influx in cardiac myocytes. Circulation 2010, 122:2273-2280.
36. 2+ exchanger. J. Neurosci. 1992, 12:430-439.
37. 2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation. J. Cell Physiol. 2007, 213:540-551.
38. 2+ activity in human cardiac fibroblasts. J. Cell Physiol. 2010, 223:68-75.
39. 2+ exchanger activity modulates connective tissue growth factor mRNA expression in transforming growth factor β1- and des-Arg10-kallidin-stimulated myofibroblasts. J. Biol. Chem. 2005, 280:14378-14384.
40. 2+ exchange in cells expressing NCX1. J. Biol. Chem. 1996, 271:22391-22397.
41. 2+ exchange inhibitors. Mol. Cell Biochem. 2004, 259:157-161.
42. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
43. 2+ concentration and nitric oxide production in vascular endothelial cells. Br. J. Pharmacol. 2000, 130:1457-1467.
44. Meguro K., Iida H., Takano H., Morita T., Sata M., Nagai R., Nakajima T. Function and role of voltage-gated sodium channel Nav1.7 expressed in aortic smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H211-H219.
45. 2+ transport ATPase by thapsigargin at subnanomolar concentrations. J. Biol. Chem. 1991, 266:13503-13506.
46. Takemura H., Hughes A.R., Thastrup O., Putney J.W. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells: evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 1989, 264:12266-12271.
47. Chuang M., Severson D.L. Inhibition of diacylglycerol metabolism in isolated cardiac myocytes by U-57 908 (RHC 80267), a diacylglycerol lipase inhibitor. J. Mol. Cell Cardiol. 1990, 22:1009-1016.
48. Dorn 2nd G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 2005, 115:527-537.
49. Venkatachalam K., Zheng F., Gill D.L. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C: regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J. Biol. Chem. 2003, 278:29031-29040.
50. Leuner K., Kazanski V., Muller M., Essin K., Henke B., Gollasch M., Harteneck C., Muller W.E. Hyperforin-a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J. 2007, 21:4101-4111.
51. Muller M., Essin K., Hill K., Beschmann H., Rubant S., Schempp C.M., Gollasch M., Boehncke W.H., Harteneck C., Muller W.E., Leuner K. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J. Biol. Chem. 2008, 283:33942-33954.
52. Blaustein M.P., Lederer W.J. Sodium/calcium exchange: its physiological implications. Physiol. Rev. 1999, 79:763-854.
53. 2+ mobilization. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L438-L447.
54. Pedersen S.F., Owsianik G., Nilius B. TRP channels: an overview. Cell Calcium 2005, 38:233-252.
55. Hofmann T., Obukhov A.G., Schaefer M., Harteneck C., Gudermann T., Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999, 397:259-263.
56. 2+-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor. J. Biol. Chem. 1999, 274:27359-27370.
57. Beech D.J., Xu S.Z., McHugh D., Flemming R. TRPC1 store-operated cationic channel subunit. Cell Calcium 2003, 33:433-440.
58. 2+ exchange. J. Biol. Chem. 2007, 282:36102-36111.
59. Smedlund K., Tano J.Y., Vazquez G. The constitutive function of native TRPC3 channels modulates vascular cell adhesion molecule-1 expression in coronary endothelial cells through nuclear factor kappaB signaling. Circ. Res. 2010, 106:1479-1488.
60. 2+ exchanger in neonatal rat cardiac myocytes. Cell Mol. Biol. (Noisy-le-grand) 1998, 44:543-551.